BIOMAT Database Logo BIOMAT Database Logo

10H-1,9-diazaphenothiazine and its 10-derivatives: synthesis, characterisation and biological evaluation as potential anticancer agents. 2019

Beata Morak-Młodawska, and Krystian Pluta, and Małgorzata Latocha, and Małgorzata Jeleń, and Dariusz Kuśmierz, and Kinga Suwińska, and Aleksander Shkurenko, and Zenon Czuba, and Magdalena Jurzak
a Department of Organic Chemistry, School of Pharmacy with the Division of Laboratory Medicine , The Medical University of Silesia , Sosnowiec , Poland.

10H-1,9-diazaphenothiazine was obtained in the sulphurisation reaction of diphenylamine with elemental sulphur and transformed into new 10-substituted derivatives, containing alkyl and dialkylaminoalkyl groups at the thiazine nitrogen atom. The 1,9-diazaphenothiazine ring system was identified with advanced 1H and 13C NMR techniques (COSY, NOESY, HSQC and HMBC) and confirmed by X-ray diffraction analysis of the methyl derivative. The compounds exhibited significant anticancer activities against the human glioblastoma SNB-19, melanoma C-32 and breast cancer MDA-MB-231 cell lines. The most active 1,9-diazaphenothiazines were the derivatives with the propynyl and N, N-diethylaminoethyl groups being more potent than cisplatin. For those two compounds, the expression of H3, TP53, CDKN1A, BCL-2 and BAX genes was detected by the RT-QPCR method. The proteome profiling study showed the most probable compound action on SNB-19 cells through the intrinsic mitochondrial pathway of apoptosis. The 1,9-diazaphenotiazine system seems to be more potent than known isomeric ones (1,6-diaza-, 1,8-diaza-, 2,7-diaza- and 3,6-diazaphenothiazine).

UI MeSH Term Description Entries
D010640 Phenothiazines Compounds containing dibenzo-1,4-thiazine. Some of them are neuroactive.
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004354 Drug Screening Assays, Antitumor Methods of investigating the effectiveness of anticancer cytotoxic drugs and biologic inhibitors. These include in vitro cell-kill models and cytostatic dye exclusion tests as well as in vivo measurement of tumor growth parameters in laboratory animals. Anticancer Drug Sensitivity Tests,Antitumor Drug Screens,Cancer Drug Tests,Drug Screening Tests, Tumor-Specific,Dye Exclusion Assays, Antitumor,Anti-Cancer Drug Screens,Antitumor Drug Screening Assays,Tumor-Specific Drug Screening Tests,Anti Cancer Drug Screens,Anti-Cancer Drug Screen,Antitumor Drug Screen,Cancer Drug Test,Drug Screen, Anti-Cancer,Drug Screen, Antitumor,Drug Screening Tests, Tumor Specific,Drug Screens, Anti-Cancer,Drug Screens, Antitumor,Drug Test, Cancer,Drug Tests, Cancer,Screen, Anti-Cancer Drug,Screen, Antitumor Drug,Screens, Anti-Cancer Drug,Screens, Antitumor Drug,Test, Cancer Drug,Tests, Cancer Drug,Tumor Specific Drug Screening Tests
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D014407 Tumor Cells, Cultured Cells grown in vitro from neoplastic tissue. If they can be established as a TUMOR CELL LINE, they can be propagated in cell culture indefinitely. Cultured Tumor Cells,Neoplastic Cells, Cultured,Cultured Neoplastic Cells,Cell, Cultured Neoplastic,Cell, Cultured Tumor,Cells, Cultured Neoplastic,Cells, Cultured Tumor,Cultured Neoplastic Cell,Cultured Tumor Cell,Neoplastic Cell, Cultured,Tumor Cell, Cultured
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular
D017209 Apoptosis A regulated cell death mechanism characterized by distinctive morphologic changes in the nucleus and cytoplasm, including the endonucleolytic cleavage of genomic DNA, at regularly spaced, internucleosomal sites, i.e., DNA FRAGMENTATION. It is genetically programmed and serves as a balance to mitosis in regulating the size of animal tissues and in mediating pathologic processes associated with tumor growth. Apoptosis, Extrinsic Pathway,Apoptosis, Intrinsic Pathway,Caspase-Dependent Apoptosis,Classic Apoptosis,Classical Apoptosis,Programmed Cell Death,Programmed Cell Death, Type I,Apoptoses, Extrinsic Pathway,Apoptoses, Intrinsic Pathway,Apoptosis, Caspase-Dependent,Apoptosis, Classic,Apoptosis, Classical,Caspase Dependent Apoptosis,Cell Death, Programmed,Classic Apoptoses,Extrinsic Pathway Apoptoses,Extrinsic Pathway Apoptosis,Intrinsic Pathway Apoptoses,Intrinsic Pathway Apoptosis
D049109 Cell Proliferation All of the processes involved in increasing CELL NUMBER including CELL DIVISION. Cell Growth in Number,Cellular Proliferation,Cell Multiplication,Cell Number Growth,Growth, Cell Number,Multiplication, Cell,Number Growth, Cell,Proliferation, Cell,Proliferation, Cellular

Related Publications

Beata Morak-Młodawska, and Krystian Pluta, and Małgorzata Latocha, and Małgorzata Jeleń, and Dariusz Kuśmierz, and Kinga Suwińska, and Aleksander Shkurenko, and Zenon Czuba, and Magdalena Jurzak
Synthesis and characterisation of celastrol derivatives as potential anticancer agents.
December 2017, Journal of enzyme inhibition and medicinal chemistry,
Beata Morak-Młodawska, and Krystian Pluta, and Małgorzata Latocha, and Małgorzata Jeleń, and Dariusz Kuśmierz, and Kinga Suwińska, and Aleksander Shkurenko, and Zenon Czuba, and Magdalena Jurzak
Synthesis, biological evaluation and mechanism studies of deoxytylophorinine and its derivatives as potential anticancer agents.
January 2012, PloS one,
Beata Morak-Młodawska, and Krystian Pluta, and Małgorzata Latocha, and Małgorzata Jeleń, and Dariusz Kuśmierz, and Kinga Suwińska, and Aleksander Shkurenko, and Zenon Czuba, and Magdalena Jurzak
Synthesis and biological evaluation of glaucocalyxin A derivatives as potential anticancer agents.
October 2014, European journal of medicinal chemistry,
Beata Morak-Młodawska, and Krystian Pluta, and Małgorzata Latocha, and Małgorzata Jeleń, and Dariusz Kuśmierz, and Kinga Suwińska, and Aleksander Shkurenko, and Zenon Czuba, and Magdalena Jurzak
Synthesis and biological evaluation of BU-4664L derivatives as potential anticancer agents.
January 2022, Bioorganic & medicinal chemistry letters,
Beata Morak-Młodawska, and Krystian Pluta, and Małgorzata Latocha, and Małgorzata Jeleń, and Dariusz Kuśmierz, and Kinga Suwińska, and Aleksander Shkurenko, and Zenon Czuba, and Magdalena Jurzak
Design, synthesis and biological evaluation of matrine derivatives as potential anticancer agents.
February 2018, Bioorganic & medicinal chemistry letters,
Beata Morak-Młodawska, and Krystian Pluta, and Małgorzata Latocha, and Małgorzata Jeleń, and Dariusz Kuśmierz, and Kinga Suwińska, and Aleksander Shkurenko, and Zenon Czuba, and Magdalena Jurzak
Synthesis and biological evaluation of novel demethylzeylasteral derivatives as potential anticancer agents.
June 2023, Fitoterapia,
Beata Morak-Młodawska, and Krystian Pluta, and Małgorzata Latocha, and Małgorzata Jeleń, and Dariusz Kuśmierz, and Kinga Suwińska, and Aleksander Shkurenko, and Zenon Czuba, and Magdalena Jurzak
Synthesis and Biological Evaluation of Telmisartan Alkylamine Derivatives as Potential Anticancer Agents.
March 2024, Anticancer research,
Beata Morak-Młodawska, and Krystian Pluta, and Małgorzata Latocha, and Małgorzata Jeleń, and Dariusz Kuśmierz, and Kinga Suwińska, and Aleksander Shkurenko, and Zenon Czuba, and Magdalena Jurzak
Synthesis and biological evaluation of benzofuran piperazine derivatives as potential anticancer agents.
September 2023, Bioorganic & medicinal chemistry letters,
Beata Morak-Młodawska, and Krystian Pluta, and Małgorzata Latocha, and Małgorzata Jeleń, and Dariusz Kuśmierz, and Kinga Suwińska, and Aleksander Shkurenko, and Zenon Czuba, and Magdalena Jurzak
Synthesis and Biological Evaluation of Quinazoline Derivatives as Potential Anticancer Agents (II).
January 2015, Anti-cancer agents in medicinal chemistry,
Beata Morak-Młodawska, and Krystian Pluta, and Małgorzata Latocha, and Małgorzata Jeleń, and Dariusz Kuśmierz, and Kinga Suwińska, and Aleksander Shkurenko, and Zenon Czuba, and Magdalena Jurzak
Synthesis and biological evaluation of novel withangulatin A derivatives as potential anticancer agents.
March 2021, Bioorganic chemistry,
Copied contents to your clipboard!